The relationship between a UCSB researcher and several victims of polycystic kidney disease has led to the development of a new designer drug that can travel through the bloodstream to the kidneys of laboratory animals
Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.
Congratulations to David Wallace on his award of a EUREKA undergraduate research internship from the Center for Science and Engineering Partnerships (CSEP) at the California Nanosystems Institute (CNSI) to support his research on polycystic kidney disease in the Weimbs lab during the Fall Quarter 2011.